Cancer patients may face higher costs as the NPPA greenlit a 50% price hike for essential Carboplatin and Cisplatin injections due to rising raw material expenses. This move aims to prevent shortages of these life-saving drugs. Prices for anti-tetanus immunoglobulin and key childhood vaccines were also adjusted to ensure availability.
